Li Cai
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting PRMT1 prevents acute and chronic graft-versus-host disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 28, 2023
A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma.
Journal: Journal of hematology & oncology
Published: July 05, 2021
Prognostic nomogram incorporating cytokines for overall survival in patients with newly diagnosed multiple myeloma.
Journal: International immunopharmacology
Published: March 10, 2021
Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival.
Journal: Breast (Edinburgh, Scotland)
Published: January 21, 2021
Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models.
Journal: Frontiers in oncology
Published: December 09, 2020
Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer.
Journal: Frontiers in immunology
Published: August 04, 2020
Role Of TP53 mutations in predicting the clinical efficacy of hypomethylating therapy in patients with myelodysplastic syndrome and related neoplasms: a systematic review and meta-analysis.
Journal: Clinical and experimental medicine
Published: January 31, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026